β-Selection-Induced Proliferation Is Required for αβ T Cell Differentiation  by Kreslavsky, Taras et al.
Immunity
Articleb-Selection-Induced Proliferation Is Required
for ab T Cell Differentiation
Taras Kreslavsky,1 Michael Gleimer,1 Masaki Miyazaki,3 Yoon Choi,2 Etienne Gagnon,4 Cornelis Murre,3 Piotr Sicinski,2
and Harald von Boehmer1,*
1Department of Cancer Immunology and AIDS
2Department of Cancer Biology
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
3Department of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA
4Institut de Recherche en Immunologie et Cance´rologie, De´partement de Microbiologie et Immunologie, Universite´ de Montre´al,
Montre´al H3T1J4, Canada
*Correspondence: harald_von_boehmer@dfci.harvard.edu
http://dx.doi.org/10.1016/j.immuni.2012.08.020SUMMARY
Proliferation and differentiation are tightly coordi-
nated to produce an appropriate number of dif-
ferentiated cells and often exhibit an antagonistic
relationship. Developing T cells, which arise in the
thymus from a minute number of bone-marrow-
derived progenitors, undergo a major expansion
upon pre-T cell receptor (TCR) expression. The burst
of proliferation coincides with differentiation toward
the ab T cell lineage—but the two processes were
previously thought to be independent from one
another, although both were driven by signaling
from pre-TCR and Notch receptors. Here we report
that proliferation at this step was not only absolutely
required for differentiation but also that its ectopic
activation was sufficient to substantially rescue
differentiation in the absence of Notch signaling.
Consistently, pharmacological inhibition of the cell
cycle machinery also blocked differentiation in vivo.
Thus the proliferation step is strictly required prior
to differentiation of immature thymocytes.
INTRODUCTION
Cell numbers in multicellular organisms have to be precisely
controlled—thus proliferation, differentiation, and cell death are
tightly coordinated both during ontogenesis and in the course
of tissue self-renewal. Dysregulation of these processes can
lead to developmental abnormalities or cancer. Adult tissues
that undergo constant self-renewal, such as blood and epithelia,
often contain slowly dividing stem cells that give rise to uncom-
mitted, in many cases frequently dividing, progenitors that have
lost their self-renewal capacity (in some tissues termed transient
amplifying cells), which in turn give rise to nonproliferating termi-
nally differentiated cells. Such hierarchical organization—with
the stem cell undergoing a limited number of divisions and
more mature progenitors being responsible for the production
of the bulk of the tissue—is thought to be required to protect840 Immunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc.stem cell DNA from mutations that accumulate in the course of
replication. Extinction of proliferation in the course of differentia-
tion, on the other hand, allows control over the number of termi-
nally differentiated cells.
The latter conjecture is often interpreted as an inherently
antagonistic relationship between proliferation and differentia-
tion. This antagonism, however, goes beyond mere correlation,
because inhibition of the cell cycle machinery in many cases
can directly trigger differentiation, whereas its ectopic activation
can suppress it (Zhu and Skoultchi, 2001). For example, forced
expression of cyclin D1 (Ccnd1) impedes myocyte differentia-
tion, whereas ectopic expression of cyclin-dependent kinase
(Cdk) inhibitors promotes expression of some differentiation
markers (Skapek et al., 1995; Manceau et al., 2008). Similarly,
repression of Ccnd1 expression by Jumonji was shown to be
required for cardiomyocyte differentiation, whereas ectopic
expression of Ccnd1 interfered with this process (Nakajima
et al., 2011). In many such cases, cell cycle proteins were sug-
gested to interfere directly with the activity of factors involved
in differentiation.
In contrast, in some cases proliferation seems to be required
for developmental progression. For instance, during differentia-
tion of helper T cells, acquisition of the ability to secrete IFNg,
IL-4, and IL-10, but not IL-2, was shown to be dependent on
proliferation by some studies (Bird et al., 1998; Richter et al.,
1999) but not others (Ben-Sasson et al., 2001; Laouar and
Crispe, 2000). Such dependence of differentiation on prolifera-
tion was suggested to reflect cell-cycle-coupled epigenetic
changes required for developmental progression (Bird et al.,
1998; Mullen et al., 2001; Murphy and Reiner, 2002). Finally,
the two processes can occur in parallel but independently from
each other (Brown et al., 2003). Thus the relationship between
differentiation and proliferation strongly depends on the cellular
context—and needs to be examined in each particular case.
In the case of T cell development, a small number of progen-
itors, which originate from hematopoietic stem cells, undergo
a dramatic expansion in the thymus. Early T lineage progenitors
(ETP) and more mature double negative (DN) 2 cells are prolifer-
ating. DN2 cells then progress to the DN3a stage. Though these
cells are often thought to be quiescent in terms of proliferation, it
has been suggested that they may also be slowly cycling (Petrie
et al., 2000). At this stage, Tcrb, Tcrg, and Tcrd rearrangement
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upon productive rearrangement of the Tcrb gene results in
a burst of proliferation and in progression to the CD4+CD8+
double positive (DP) stage—a hallmark of ab T cell lineage
commitment. This process is called b selection. The majority of
DP cells are nondividing, as are CD4 and CD8 single positive
thymocytes. Thus one can view all thymocyte populations prior
to the DP stage as transient amplifying cells, with the largest
amplification triggered by b selection.
Signals from a number of receptors, including the pre-TCR,
the IL-7R, Notch (Ciofani et al., 2004; Maillard et al., 2006), and
CXCR4 regulate proliferation and developmental progression
upon b selection. A recent study utilizing a reductionist feeder-
free cell culture system identified pre-TCR and Notch signaling
as the only two pathways strictly required for both proliferation
and differentiation—with others playing modulatory roles (Tussi-
wand et al., 2011).
The burst of proliferation that takes place upon b selection
serves to amplify cells with productive Tcrb rearrangements,
and thus maximizes TCR diversity – as the same TCRb can later
pair with different TCRa chains. It was previously reported that
proliferation per se was not required for developmental progres-
sion, because Myc-deficient DN3 thymocytes were able to
generate DP cells in the apparent absence of cell division
(Dose et al., 2006). Moreover, DP cells were found in the thymi
of cyclin D3 (Ccnd3)-deficient mice, where thymocyte prolifera-
tion is severely impaired (Sicinska et al., 2003). These results
suggested that proliferation and differentiation after b selection
coincide but are independent of each other. However, careful
analysis of thymocytes from Ccnd3- andMyc-deficient mice re-
ported here revealed that, like for WT thymocytes, only those
cells that divide several times gave rise to DP cells. Moreover,
reversible inhibition of proliferation by several compounds with
biochemically distinct modes of action, which block cell cycle
at different stages, also resulted in a complete block of DP cell
progression. Treatment of mice with a Cdk4 and Cdk6 inhibitor
led to a complete block in the DN3-to-DP transition, suggesting
that the same rules apply in vivo. Ectopic activation of the cell
cycle machinery, although unable to compensate for the lack
of pre-TCR signaling, substantially rescued differentiation of
precursors in the absence of Notch ligands. Rescue of prolifera-
tion and differentiation in the absence of Notch signaling was
also achieved by ectopic expression of a single Notch target—
the transcription factor Myc—a known positive regulator of
proliferation and metabolism. Another transcription factor, E47
(encoded by Tcf3), was required to make developmental
progression dependent on proliferation as Tcf3/ cells were
able to progress to the DP stage without cell division. Thus, at
the b-selection checkpoint, proliferation was required for differ-
entiation of ab T cells, and its ectopic activation was sufficient
to rescue differentiation in the absence of one of the two key
molecular pathways required at this stage—Notch signaling.
RESULTS
A Tight Link between Proliferation and Differentiation
at the DN3-to-DP Transition
We noticed that when CFSE-labeled pre-b-selection DN3a
thymocytes were plated on OP9-DL1 monolayers, only cellsIthat had divided four times or more progressed to the DP stage
efficiently (Figure 1A). Both proliferation and differentiation at
this stage of T cell development are triggered by productive re-
arrangement of Tcrb that results in the expression of the pre-
TCR. The simplest explanation for this correlation was that the
time required for a b-selected cell to progress to the DP stage
was sufficient for this number of cell divisions. Indeed, several
studies suggest that progression to the DP stage can take place
in the absence of proliferation. When Myc was deleted in DN3
cells, CD4 and CD8 were upregulated on thymocytes in OP9-
DL1 cocultures in the absence of proliferation in culture (Dose
et al., 2006). However, total DN3 cells that include both pre-
and post-b-selection cells were used in this study. When we re-
visited this question using pre-b-selection DN3a cells from these
mice, we noticed that only a minor fraction of the cells pro-
gressed to the DP stage and that this progression was always
associated with cell division (Figure 1B). In contrast, DN3b cells,
some of which underwent proliferation in vivo, were able to prog-
ress to the DP stage without further cell division in culture (Fig-
ure 1B). Ex vivo DN3b cells had more of the nondeleted Myc
allele than did their DN3a precursors (see Figure S1 available on-
line)—suggesting that cells that did not delete Myc had a better
chance to progress further in development. These DN3b cells,
however, seemed to delete Myc quickly thereafter as very low
levels of the nondeleted allele could be detected in their imme-
diate progeny—the transitional CD25int DN3b-DN4 population
(Figure S1). It is unclear whether all the cells that progressed
beyond the DN3a stage deletedMyc late (or had a higher starting
level of the Myc protein for other reasons) or whether some
differentiation could take place in the true absence of Myc. In
either case, it is safe to conclude that, similarly as in WT cells,
differentiation of Lck-Cre Mycfl/fl DN3a precursors is associated
with cell division.
It was also shown that cyclin D3 (Ccnd3) was required for effi-
cient proliferation at the b-selection checkpoint, even though
Ccnd3/ thymi contained some DP thymocytes (Sicinska
et al., 2003). Accordingly, Ccnd3/ DN3a cells divided slower
in culture (Figure 1C). If WT cells were starting to upregulate
CD4 and CD8 coreceptors after four divisions simply because
differentiation takes the same amount of time as several cell
cycles, then slowly dividing cyclin D3-deficient cells should
progress to DP stage synchronously with WT cells, but after
going through fewer divisions. This was not the case: deceler-
ated proliferation of Ccnd3/ precursors was associated with
delayed progression to the DP stage (Figure 1C). Again, only
cells that divided several times activated CD4 and CD8 expres-
sion. These observations hinted at the intriguing possibility that
proliferation was required for the progression to DP stage.
Progression through the Cell Cycle Is Required
for ab T Cell Differentiation
To test whether proliferation upon b-selection was required
for differentiation of ab lineage cells, we aimed to assay the
differentiation status of DN3 cells under conditions where cell
cycle progression was inhibited. To this end, we utilized
PD0332991—a highly specific inhibitor of cyclin-dependent
kinases 4 and 6. To increase survival of the cells in the presence
of this and other compounds, we used Vav-Bcl2 transgenic
thymocytes in the experiments utilizing inhibitors. Similar resultsmmunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc. 841
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Figure 1. ab T Cell Differentiation Is Associated with Proliferation in WT and Genetically Manipulated Mice
(A) WT DN3a cells were sorted, labeled with CFSE, and placed in OP9-DL1 coculture. CFSE dilution and CD4 and CD8 expression were analyzed 4 days later.
CFSE dilution versus CD4 and CD8 expression (summed electronically) (left) and expression of CD4 and CD8 individually on divided and undivided cells (center
and right) is shown.
(B) DN3a and DN3b cells from WT and Mycfl/fl Lck-Cre were treated and analyzed as in (A).
(C) CellTrace Violet-labeled Ccnd3/ and Ccnd3+/ DN3a cells were placed in OP9-DL1 cocultures for 4 (top panels) or 8 (bottom panels) days. Dilution of
CellTrace Violet, and expression of CD4 andCD8was assessed. Numbers aboveCellTrace Violet dilution plots represent the number of divisions. Note the dulling
of CellTrace Violet from day 4 to day 8. Representative results of two independent experiments are shown. See also Figure S1.
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ure S2A; data not shown). Addition of PD0332991 to DN3a-
OP9-DL1 cocultures blocked proliferation of the thymocytes
(Figure 2A) without any obvious toxic effects on the Bcl2-
transgenic precursors or feeder cells. The block of proliferation
coincided with a block in DP progression (Figure 2B). When
the cells were resorted from these cultures and plated on fresh
OP9-DL1 feeders in the absence of inhibitor, they regained the
ability to divide—and only the dividing cells progressed to the
DP stage (Figures 2A and 2B).
Although this result supported the hypothesis that the wave of
proliferation upon b selection was required for ab lineage differ-
entiation, alternative explanations were possible. It was sug-
gested recently that Cdk6 activity itself may be directly required
for ab T cell differentiation (Hu et al., 2009, 2011). It was also
possible that PD0332991 had off-target effects unrelated to
cell cycle that led to a block in T cell development. Thus we
tested a panel of cell cycle inhibitors that block cells at G1, S,
or G2-M stages. All inhibitors that blocked proliferation also
interfered with developmental progression (Figures 2C and
2D). At no concentration of any inhibitor could the block in
differentiation be uncoupled from the block in differentiation
(Figure S2B, results for PD0332991, purvalanol A and for the
thymidine block are shown). Importantly, multiple inhibitors
blocked cells at the S and G2-M stages of the cell cycle and
thus should not interfere with Cdk6 function (shown below for
thymidine block), arguing against the possibility that the block
in differentiation was a direct consequence of the missing
Cdk6 activity. Although all of the inhibitors blocked thymocytes
at the expected cell cycle stage, few affected density (aphidi-
colin) or morphology (L-mimosine, colcemid, nocodazole) of
OP9 cells. Further experiments were mostly performed with
PD0332991, the inhibitor described above, and the thymidine
block—1 mM thymidine treatment that causes feedback inhibi-
tion of nucleotide synthesis and blocks cells at the S stage—
neither had any adverse effect on OP9DL1 survival or mor-
phology. As expected, PD0332991, but not thymidine, interfered
with Cdk activity as judged by severely reduced phosphorylation
of their key target—Rb—on Ser773 (a cyclin-D-Cdk4- and
cyclin-D-Cdk6-specific site) (Figure S2C). The thymidine block
could be rescued both in terms of proliferation and differentiation
by supplementing the medium with nucleosides (Figure S2D). To
exclude the possibility that the inhibitors kill DP cells, we cultured
sorted Vav-Bcl2 Tg DP cells in their presence or absence and
found similar cell numbers (Figure S2E).
One explanation for the observed developmental block would
be the inability of the cells to rearrange their Tcrb in the presence
of the inhibitors. To address this, we first carefully assessed the
influence of the compounds on the frequency of IC TCRb+ cells.
The staining was highly specific as judged by lack thereof on
Rag2-deficient cells. Because after 4 days of culture IC TCRb+
cells in the absence the inhibitors had divided, we calculated
their ‘‘adjusted frequency’’ (as if they did not divide) on the basis
of CellTrace Violet dilution as described in Figure S2F. This
approach allowed a direct comparison of TCRb expression
between cells cultured with or without inhibitors. Several com-
pounds, including PD0332991 used throughout this study, did
not have any adverse effect on TCRb expression, whereas
others caused some decrease in frequency of IC TCRb+ cellsI(but in all such cases the frequency was several fold higher
than in the postsort population) (Figure S2F). We then sorted
and cultured HY TCRb-transgenic DN3a cells; their differentia-
tion was likewise blocked by the inhibitors (Figure S2G). We
conclude therefore that the developmental block observed in
the absence of proliferation cannot be attributed to the inability
to rearrange Tcrb.
Blocking of the cell cycle did not merely interfere with CD4 and
CD8 coreceptor induction—because upregulation of RORgt,
a key regulator of DP thymocyte survival (Sun et al., 2000), was
also severely inhibited in the absence of proliferation (Figure 3A).
Likewise, CD25, normally downregulated upon b selection, re-
mained equally expressed on IC TCRb-positive and -negative
cells when proliferation was inhibited (Figure 3B). Interestingly,
however, the Tcra locus, which normally becomes transcription-
ally active and is rearranged only at the DP stage, was still rear-
ranged in the presence of some but not all of the inhibitors—as
judged by presence of surface TCRb+ cells, some of which
stained with a cocktail of Va antibodies (Figure S3). The fact
that some inhibitors allowed for surface TCR expression and
others did not may reflect the destabilization of Rag2 in the
S-phase, thought to be mediated by direct phosphorylation
from Cdks (Lee and Desiderio, 1999; Li et al., 1996). Thus,
although proliferation was required for execution of develop-
mental program broader than CD4 and CD8 upregulation,
some important events in ab T cell differentiation—such as
Tcra rearrangement—were proliferation-independent. Neverthe-
less, because no conventional ab T cell can develop in the mere
absence of just the coreceptors, it is fair to conclude that
proliferation is required for ab T cell differentiation.
We next sought to find in vivo evidence for a proliferation
requirement in ab T cell differentiation. As all the available
genetic tools (such as cyclin D3 knockout) block cell cycle
progression of b-selected thymocytes only partially, we again
took a pharmacological approach and treated wild-type mice
with PD0332991 by gastric gavage. Overall thymic cellularity of
treated mice was reduced about 30-fold, but DN3 cells were still
present on day 5 after the beginning of treatment. Their progres-
sion to the DP stage was, however, completely blocked as
judged by a reduction of the DP compartment to less than 1%
of the remaining thymocytes and, most strikingly, a complete
absence of newly generated TCRb/low DP cells (Figure 3C).
Although this in vivo experiment by itself could not discriminate
between cell-autonomous and non-cell-autonomous effects of
the compound, together with the bulk of cell culture data pre-
sented above it provided support for the notion that proliferation
was indispensible for DP progression both in vitro and in vivo.
The Ability to Differentiate Is Acquired Gradually
over Several Cell Divisions
As developing thymocytes showed a strong correlation between
the number of cell divisions and their differentiation status, with
only those that divided four times or more progressing to the
DP stage efficiently (Figure 1A), we next tested how many cell
divisions were in fact required. To this end, we plated CellTrace
violet-labeled DN3a thymocytes on OP9-DL1 monolayers,
cultured them for 3 days, resorted cells that went through various
numbers of cell divisions, and placed them into secondary
cultures in the presence or absence of 1 mM thymidine. In themmunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc. 843
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Figure 2. Proliferation Is Required for ab T Cell Differentiation
CellTrace violet-labeled Vav-Bcl2 transgenic DN3a cells were cultured on OP9-DL1 monolayers in the presence or absence of 1 mMPD0332991 cdk inhibitor for
2 days; undivided undifferentiated cells were resorted and cultured for additional 3 days with or without the inhibitor. Expression of CD4 and CD8 (A and B) and
CellTrace violet dilution (A) was analyzed at both time points.
(C and D) CellTrace violet-labeled Vav-Bcl2 transgenic DN3a cells were cultured in the presence or absence of the indicated inhibitors (for concentrations, see
Supplemental Experimental Procedures). On day 4, CD4 and CD8 upregulation (C) and CellTrace violet dilution (D) were analyzed. See also Figure S2.
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Figure 3. Proliferation Dependence of the ab T Cell Program Is Not Limited to CD4 and CD8 Coreceptor Upregulation and Holds True In Vivo
(A and B) CellTrace violet-labeled Vav-Bcl2 transgenic DN3a cells were cultured onOP9-DL1monolayers in the presence or absence of 1 mMPD0332991 or 1mM
thymidine for 3 days, stained for surface expression of CD25 and intracellular expression of TCRb and RORgt. RORgt (A) and CD25 (B) expression is plotted
against CellTrace violet dilution (top) or is compared in TCRb+ and TCRb cells (bottom).
(C) WT mice were treated with PD0332991 or vehicle for 5 days as described in Supplemental Experimental Procedures. Expression of CD4 and CD8 on Lin
(Gr1CD11bCD11cCD19Ter119NK1.1) thymocytes (left), surface expression of TCRb on LinCD4+CD8+ cells (center) and CD44 versus CD25 expression
on DN LinTCRb thymocytes (right) are shown. See also Figure S3.
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generate DP cells. Importantly, the efficacy of the DP pro-
gression was very similar for all populations that divided at least
once in primary culture (Figure 4). However, the presence of the
inhibitor revealed that the ability to differentiate was acquired
gradually over several cell divisions, plateauing at around 4–5
divisions (Figure 4). Thus not only progression through cell cycle
was required for ab T cell differentiation, but several rounds of
cell division were necessary to make this process efficient.
Ectopic Activation of Proliferation Is Insufficient to Drive
DP Progression in the Absence of pre-TCR Expression
Both pre-TCR and Notch signaling is strictly required for DP
progression—and both pathways are mitogenic at this stage.
We therefore asked whether ectopic activation of proliferation
may rescue development in the absence of one of them. To
this end, we first utilized retroviral overexpression of various
components of cell cycle machinery in Rag2-deficient DN3 cellsIwith a Vav-Bcl2 transgene (to compensate for the pro-survival
role of the pre-TCR), generated in OP9-DL1 coculture from
hematopoietic stem cells. Previously, it was shown that ectopic
Bcl2 expression driven by Lck (Linette et al., 1994) but not Em
(Maraskovsky et al., 1997) regulatory elements in Rag/ mice
could cause the appearance of DP cells. Indeed, Vav-Bcl2 tg
Rag2/ mice had 30%–40% of DP cells in the thymus (Fig-
ure S4A). However, in OP9-DL1 cocultures, DP progression of
Vav-Bcl2 tg Rag2/ DN3 cells was extremely slow, with small
numbers of DP cells detectable as late as day 9, correlating
with the very slow proliferation of these cells (Figure S4B, C).
This provided us with a time window sufficient for overexpres-
sion strategies.
Entry into the cell cycle and transition through the G1 phase
are governed by the coordinated action of the D- and E-type
cyclins, which activate their catalytic partners, cyclin-depen-
dent kinases Cdk4, Cdk6, and Cdk2. Indeed, abundance of
cyclin D3 protein was shown to increase dramatically uponmmunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc. 845
BA Figure 4. Several Rounds of Cell Division
Are Required for Efficient Progression to
the DP Stage
Vav-Bcl2 transgenic DN3a cells were sorted,
labeled with CellTrace violet, and placed in OP9-
DL1 coculture. On day 3, individual CellTrace
violet peaks corresponding to different number of
cell divisions were sorted and cells were placed
into secondary OP9-DL1 coculture with or without
1 mM thymidine to block further divisions.
Expression of CD4 and CD8 was assessed after
2 days of secondary culture. Representative FACS
plots (A) and frequency of DP cells in the cultures
(B) are shown. Because the cell cycle block was
not always complete, letting some cells undergo
one more division, additional gating on cells that
did not divide in secondary cultures was applied
for cultures in the presence of thymidine. Repre-
sentative results of three independent experi-
ments are shown.
Immunity
DN3 Thymocytes Need Proliferation to Differentiateb selection (Sicinska et al., 2003), and expression of cyclins E1
(Ccne1) and E2 (Ccne2) was likewise induced in DN3b cells
(Immgen.org). We observed that forced expression of individual
cyclins drove some proliferation of Vav-Bcl2 tg Rag2/ DN3
cells; however, the proliferation rate was lower than that driven
by TCRb expression (Figure 5B, cyclin D3 overexpression is846 Immunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc.shown). Thus, we designed a cassette
(termed ‘‘proliferator’’) containing cyclins
D3 and E1 together with their partner
Cdks (Cdk6 and Cdk2, respectively) all
joined by P2A peptides (Figure S5A)
that cause ribosomal skipping; thus,
four polypeptide chains are generated
from one messenger RNA. Expression
of this cassette resulted in a burst of
proliferation comparable to that induced
by TCRb expression when both delivered
retrovirally into Vav-Bcl2 tg Rag2/ DN3
cells (Figure 5A). However, unlike TCRb
expression, it was insufficient to drive
developmental progression of the cells
(Figure 5B). Importantly, neither ‘‘prolifer-
ator’’ nor cyclin D3 alone interfered with
differentiation of Rag2-sufficient cells
(Figure 5C). Thus, although proliferation
was required for DP progression, its
ectopic activation was insufficient to
drive differentiation of ab T cells in the
absence of pre-TCR signaling.
Ectopic Activation of Proliferation
Rescues Differentiation in the
Absence of Notch Signaling
Notch signaling is another pathway
crucial for the progression of cells to the
DP stage. We thus tested whether ex-
pression of the ‘‘proliferator’’ cassette
could rescue proliferation and differentia-tion in the absence of Notch signaling. To this end, we infected
DN3a cells generated in OP9-DL1 coculture from Vav-Bcl2
transgenic hematopoietic stem cells with the ‘‘proliferator’’-
encoding retrovirus or empty vector (transgenic expression of
Bcl2 was required to compensate for the well-established pro-
survival role of Notch signaling at this stage [Ciofani et al.,
BA
C
Figure 5. Ectopic Activation of Proliferation Is Insufficient to Compensate for the Lack of pre-TCR Signaling
(A and B) DN3 cells generated in OP9-DL1 cocultures from Vav-Bcl2 transgenic Rag2/ HSCs were infected with retroviruses encoding IRES-GFP, Ccnd3-
IRES-GFP, proliferator-IRES-GFP, or TCRb-IRES-GFP, sorted, labeled with CellTrace Violet, and plated again on OP9-DL1 monolayers. Six days later,
CellTrace violet dilution (A), gated on GFP+ cells), and CD4 and CD8 upregulation (B) were assessed. Representative results of four independent experiments
are shown.
(C) Differentiation of Vav-Bcl2 Tg, Rag-sufficient cells treated as in (B) is shown. See also Figure S4.
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tolerance ofwtDN3a cells to proliferator expression (Figure S5B).
Because our previous experiments demonstrated that prolifera-
tor was able to drive division of pre-TCR negative cells (Figure 5),
gating on intracellular TCRb-positive cells—to focus on the cells
that actually had the potential to differentiate—was applied in
these experiments. Both empty vector and proliferator infected
cells were able to divide and differentiate on OP9-DL1 feeders
(Figure 6A). As expected, in the absence of Notch signaling,
empty vector-infected cells were almost completely stalled,
both in terms of proliferation and differentiation. However, ex-Ipression of proliferator forced cells to divide even in the absence
of Notch signaling, although the rescue of proliferation, unlike in
the case of pre-TCR signaling, varied between experiments.
However, in all cases where cells divided three or more times,
proliferation was accompanied by a substantial rescue of differ-
entiation (Figure 6A).
Notch is thought to regulate proliferation of b-selected thymo-
cytes at least in part via direct induction of Myc (Weng et al.,
2006). Thus, we tested whether ectopic Myc expression could
drive proliferation in the absence of Notch signaling and whether
that in turn might rescue their differentiation. To this end,mmunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc. 847
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Figure 6. Ectopic Activation of Proliferation Rescues DP Progression in the Absence of Notch Signaling
(A) DN3 cells generated in OP9-DL1 cocultures from Vav-Bcl2 transgenic HSCs were infected with retroviruses encoding IRES-GFP or proliferator-IRES-GFP,
sorted, labeledwith CellTrace Violet and plated again onOP9-DL1 or control OP9monolayers. Six days later cells were harvested, stained for surfaceCD45, CD4,
and CD8 expression, fixed, permeabilized, and stained for intracellular TCRb. CellTrace violet dilution (right) as well as CD4 and CD8 upregulation (left) were
analyzed in CD45+IC TCRb+GFP+ cells. Representative results of five independent experiments in which proliferator-infected cells divided three times ormore are
shown.
(B and C) Cells were generated, infected with Myc-IRES-GFP or empty vector, cultured, and analyzed as in (A). Myc-infected cells were cultured in presence or
absence of 1 mM PD0332991. CellTrace violet dilution (B, right), CD4 and CD8 upregulation (B, left) were analyzed in CD45+IC TCRb+GFPhi cells. (C) shows GFP
versus CellTrace violet and GFP versus CD8 plots for Myc-infected CD45+IC TCRb+ cells. Representative results of three independent experiments. See also
Figure S5.
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infected with Myc-IRES-GFP retrovirus or empty vector and
placed on OP9-DL1 or control OP9 feeders (WT cells did not
tolerate high level of Myc expression [Figure S5C]). GFP+
Myc-infected DN3a cells proliferated and efficiently progressed
to the DP stage in the absence of Notch signaling (Figure 6B)
and both proliferation and differentiation were restricted to the
GFPhi population (Figure 6C). Notch-independent proliferation
and differentiation of Myc-IRES-GFP-expressing cells was
readily blocked by PD0332991, suggesting that induction of
proliferation was an important part of Myc-mediated rescue (Fig-
ure 6B). We next tested how the level of Myc that enables DP
progression in the absence of Notch ligands relates to the level
physiologically induced by Notch signaling. Specificity of the
Myc antibody was first confirmed by staining thymocytes
infected with a retrovirus encoding mouse Myc-IRES-GFP (Fig-
ure S5D). As was previously reported, Myc was downregulated
in DP cells (Figure S5F, left). Strikingly, the level of Myc protein
dropped to virtually undetectable in the cells cultured without
Notch signaling, suggesting that Myc expression was strictly
Notch-dependent at this stage of T cell development (Figure S5F,
center). Ectopic expression of mouse Myc that was able to
rescue progression to the DP stage (Figure S5E) restored Myc
expression in the absence of Notch signaling to a physiological
level, although expectedly DP cells failed to downregulate
ectopically expressedMyc (Figure S5F, right) while the presence
of Notch signaling resulted in overexpression (data not shown).
Thus, activation of the cell cycle machinery—directly or via
ectopic expression of a single Notch target—Myc—can com-
pensate, at least in part, for the lack of Notch signaling at the
b-selection checkpoint.
Transcription Factor E47 Imposes the Dependence
of Differentiation on Proliferation
E47, one of the two E-protein family transcription factors
encoded by Tcf3 gene, was suggested to play the role of a gate-
keeper of differentiation at the b-selection checkpoint, as its
activity drops upon b selection and in its absence thymocytes
progress to the DP stage even without TCR rearrangement (En-
gel et al., 2001). We compared differentiation of DN3a cells from
WT and E47-deficient (referred here and below as Tcf3/, note
that only a E47-specific exon is disrupted in this mouse [Bain
et al., 1997]) mice in the presence or absence of the cell cycle
inhibitor. Strikingly, Tcf3/ DN3a thymocytes, unlike their WT
counterparts, were able to progress to the DP stage without
a single cell division (Figure 7A) (note that only a fraction of undi-
vided cells would express the pre-TCR). Even without cell cycle
inhibitor, E47 deficient precursors upregulated coreceptors
after fewer cell divisions than their WT counterparts in parallel
cultures (Figures 7A and 7C). These results are unlikely to be ex-
plained by excessive proliferation of Tcf3/ cells in vivo as WT
and null mutant DN3a cells did not show major differences in
their cell cycle status (Figure 7B). Importantly, sorted E47-defi-
cient cells did not exhibit increased frequency of IC TCRb+ cells
(data not shown) and thus represent bona fide DN3a cells.
Precursors, deficient in another E protein— HEB (encoded by
Tcf12)—that has both overlapping and distinct functions with
E47 in T cell development, failed to differentiate when prolifera-
tion was blocked (Figure S6A). In fact, DN3a cells from Tcf12fl/flIIL7RCre mice, used in these experiments, exhibited prolifera-
tion-dependent accumulation of CD8+CD4 ISP cells consistent
with the in vivo phenotype of Tcf12 knockouts (Barndt et al.,
1999) and slower proliferation. Thus, expression of E47, but
not HEB, made further development of DN3a cells dependent
on proliferation.
E47 is believed to be inactivated upon b selection by rapid
induction of Id3, which heterodimerizes with E proteins and
prevents their binding to DNA, and by a decline in E47 protein
abundance. However, neither was affected by proliferation as
judged by normal induction of an Id3-GFP reporter in the pres-
ence of cell cycle inhibitors and lack of obvious downregulation
of the product of Tcf3GFP fusion allele where the GFP level corre-
lated with the cell size rather than with the number of divisions
(Figures 6C and 6D).
As Tcf3/ thymocytes were able to progress to the DP stage
without proliferation, and the results above suggest that a mito-
genic role of Notch signaling in DN3-to-DP transition may in
part be upstream of its role in differentiation, we next assessed
development of Tcf3/ precursors in the absence of Notch
signaling. Like WT precursors, these cells failed to proliferate
without Notch signaling, but, unlike WT cells, still were able
to generate DP cells at variable, but substantial frequencies
(30% ± 17% for KO versus 2.4% ± 1.5% for WT, n = 5) in the
absence of Notch ligands (Figure 7C). Thus E47 deficient cells
were not only able to progress to DP stage without proliferation
but also couldmake this developmental transition in the absence
of Notch signaling.
DISCUSSION
Proliferation and differentiation are often antagonistic. Here we
report that, to the contrary, pre-TCR-induced Notch-dependent
proliferation of b-selected thymocytes was indispensable for
their differentiation and that several cell divisions were required
for efficient progression to theDP stage.Moreover, development
in the absence of Notch, but not in the absence of the pre-TCR,
was substantially rescued by ectopic activation of the cell cycle
machinery in DN3 thymocytes.
Why proliferation triggered by b selection is required for the
differentiation of ab T cells remains a mystery. One possibility is
that acomponentof thecell cyclemachineryactivatedatacertain
stage of the cycle plays a direct role in the induction of differenti-
ation. Indeed, it was suggested that Cdk6was directly involved in
thymocyte differentiation, perhaps through modulation of Notch
signaling (although evidence for the latter is incomplete) (Hu
et al., 2011). We demonstrated, however, that blocking the cell
cycle as late as S and G2-M phases (which allowed for normal
activation of Cdk6 in G1 as demonstrated here by normal phos-
phorylation of Rb in the case of thymidine block) interfered with
differentiation.Moreover, progression through several cell cycles
was required for efficient differentiation. Nevertheless, it remains
possible that periodic activity of the cell cyclemachinery (or some
of its components), rather than cell division per se, is directly
required for progression to DP.
In the system where proliferation was shown to be required for
helper T cell differentiation, it was suggested to act via cell cycle-
coupled epigenetic changes, which in turn were necessary for
derepression of lineage-specific genes (Bird et al., 1998; Mullenmmunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc. 849
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Figure 7. Tcf3–/– DN3a Cells Can Progress to the DP Stage without Proliferation
(A) WT or Tcf3/ DN3a cells were labeled with CellTrace violet and placed in OP9-DL1 cocultures in the presence or absence of 1 mM PD0332991. CellTrace
violet dilution as well as CD4 and CD8 expression was analyzed on day 3.
(B) Cell cycle status of ex vivo WT or Tcf3/ DN3a and DN3b thymocytes was analyzed by DAPI staining.
(C) WT or Tcf3/DN3a cells (from bm chimeras, as described in the Supplemental Experimental Procedures) were labeled with CellTrace violet, placed on OP9-
DL1 or control OP9 monolayers, and analyzed as in (A). See also Figure S6.
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DN3 Thymocytes Need Proliferation to Differentiateet al., 2001;Murphy andReiner, 2002). In one particular example,
treatment of naive T cells differentiating toward Th1 or Th2
lineages with 5-azacytidine, a methyltransferase inhibitor that
interferes with DNA methylation, enabled expression of cytokine
genes after a lower number of divisions (Bird et al., 1998).
However, treatment of DN3a cells with 5-azacytidine not only
failed to enhance differentiation, but in fact interfered both with
their proliferation and developmental progression (data not
shown). Nevertheless, the idea that proliferation-dependent
epigenetic changes are required for the progression to the DP
stage remains plausible.
Although the full mechanism that couples differentiation to
proliferation has yet to be described, the transcription factor
E47 encoded by Tcf3 gene was identified here as one of its
gears, because without it the two processes could be readily un-
coupled. However, neither of the two ways of E47 inactivation
that were shown to act in thymocytes (pre-TCR-induced ex-
pression of Id3 and a decline in E47 protein abundance) were
dependent on proliferation. It is thus possible that different
means of E protein inactivation described in other systems (re-
viewed in Braunstein and Anderson [2012]) also play a role at
the b selection and are coupled to proliferation. It is also conceiv-
able that the history of E47 expression (possibly through epige-
netic changes), rather than its actual expression at b selection
checkpoint, is required tomake the DN3-to-DP transition depen-
dent on proliferation. Consistent with the later hypothesis, our
attempts to delete a floxed allele of Tcf3 in culture with recombi-
nant tat-Cre treatment or ER-Cre, unlike a germline deficiency,
was insufficient to uncouple differentiation from proliferation
(data not shown), although this may be due to an insufficient
deletion efficiency or residual E47 protein. The fact that HEB
deficiency failed to uncouple differentiation from proliferation
may indicate that this function is qualitatively unique for E47 or
that quantitative differences in overall E protein activity are
changed differently by the removal of HEB and E47. Of interest,
Tcf3/ DN3a cells were also able to progress to DP stage in
the absence of Notch signaling. Notch signaling can down-
modulate E protein activity (Nie et al., 2003) and does so in coop-
eration with pre-TCR at b selection checkpoint (Lauritsen et al.,
2009). Consistent with this model, decreased E protein abun-
dance in Tcf3/ cells may render ab differentiation partially
Notch independent.
Genetic manipulation of several cell cycle-related genes was
previously reported to cause alterations in T cell development.
Knockout of Ccnd3 (Sicinska et al., 2003), Cdk6 (Hu et al.,
2009), and a kinase-dead knockin of Cdk6 (Hu et al., 2011), as
well as ectopic expression of the cell cycle inhibitor p19Arf
(encoded by Cdkn2a) under the Lck promoter (Miyazaki et al.,
2008) all led to a prominent block in the DP progression—in
line with observations reported here. Often, such results were
interpreted as evidence for a role of the cell cycle protein of
interest in the differentiation of thymocytes. Our results support
this view but suggest that their role in T cell differentiation
mayat least inpart bedownstreamof their role in thymocyteprolif-
eration. Surprisingly, Notch signaling likewise seems to exemplify
here themodelwhere the role of amolecular pathway in cell differ-
entiation is at least in part downstream of its mitogenic function.
Notch signaling is required for the DN3-to-DP progression
(Ciofani et al., 2004; Maillard et al., 2006); however, the exactIfunction of Notch at this transition remained elusive. Early in
T cell development, Notch is required for the induction of key
transcription factors that specify T cell fate—Bcl11b, Hes1, and
TCF-1 (encoded by Tcf7) (reviewed in Rothenberg [2012]).
However, by the DN3 stage, Notch signaling is not required for
the maintenance of Bcl11b and Tcf7 expression (unpublished
data).Hes1, which is still regulated by Notch in DN3 thymocytes,
is already dispensable at this stage (Wendorff et al., 2010). It was
previously shown that Notch signaling plays a crucial role via
regulation of cell survival and metabolism at the b selection
checkpoint (Ciofani and Zu´n˜iga-Pflu¨cker, 2005). However,
ectopic Bcl2 expression, although compensating for the prosur-
vival effects ofNotch, could not rescuedifferentiation (Kreslavsky
et al., 2010). Our observation that proliferation was required for
the differentiation, together with the well-established mitogenic
role of Notch signaling at this stage, prompted us to test whether
ectopic activation of the proliferation machinery would rescue
T cell differentiation in the absence of Notch signaling. This
was indeed the case. The achieved rescue of proliferation was
partial, which may explain the substantial but incomplete rescue
of differentiation. It is also likely that other functions of Notch,
such as regulation of thymocyte metabolism (Ciofani and Zu´-
n˜iga-Pflu¨cker, 2005), may contribute to the DP progression.
We next sought to understand the molecular mechanism
downstream of Notch that licenses b-selected thymocytes to
proliferate. It was shown that the transcription factor Myc—
a common downsream effector of multiple mitogenic signals—
is a direct Notch1 target in T cell acute lymphoblastic leukemia
(T-ALL) and that its expression at the b selection checkpoint is
likewise Notch-dependent (Weng et al., 2006). DN3 cells ex-
hibited severely reduced proliferation upon conditional deletion
of Myc (Dose et al., 2006; Figure 1). However, it was recently
reported that ectopic expression of Myc was able to rescue
expansion but not differentiation of thymocytes at b selection
checkpoint in the absence of Notch signaling (Wong et al.,
2012), potentially contradicting our observations with the prolif-
erator construct. To resolve this discrepancy, we reassessed the
effects of Myc overexpression on Notch dependence of devel-
oping thymocytes. Strikingly, Vav-Bcl2 transgenic DN3a cells,
expressing high amounts of Myc-IRES-GFP in the absence of
Notch signaling, were rescued both in terms of proliferation
and differentiation. Non-bcl2 transgenic cells, however, could
not be rescued, possibly because they expressed lower levels
of Myc-IRES-GFP, a likely explanation for the seeming discrep-
ancy with Wong et al. (2012). Different sources of the precursors
(fetal liver versus adult HSC), absence of IL-7, that is inhibitory
for DP progression (Tussiwand et al., 2011) in our cultures or
different level of Myc expression may also contribute to the
difference. An obvious threshold in Myc expression (Figure 6C)
that was required for the rescue is a plausible explanation of
our own previous failure to render T cell differentiation and
proliferation Notch-independent by this approach on ex vivo
thymocytes that are poorly infectable (Kreslavsky et al., 2010).
Importantly, level of Myc ectopic expression required to rescue
progression to the DP stage was within physiological range.
Here we demonstrate that two pathways: pre-TCR and
Notch signaling—both required for proliferation and conducive
for DP progression—regulate these processes in different
ways. Whereas the mitogenic role of the pre-TCR was requiredmmunity 37, 840–853, November 16, 2012 ª2012 Elsevier Inc. 851
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tional direct effect of this signaling pathway on differentiation, the
mitogenic role of Notch appeared to be to a large extent
upstream of its function in supporting the differentiation of DN3
thymocytes to the DP stage. A situation where the same
signaling pathway regulates both developmental progression
and proliferation of a cell is common both in normal cell differen-
tiation and in tumorigenesis. It may thus be of interest to test
whether the relationship between proliferation and differentiation
in some of these systems resembles Notch or pre-TCR signaling
at the b selection checkpoint. The ‘‘proliferator’’ cassette
described here may be a useful tool to address this question in
other developmental systems. Further study of the molecular
mechanisms underlying the link between differentiation and
proliferation may illuminate the initiating mechanisms of tumori-
genesis—in particular, that of T-ALL—a common human cancer
that originates specifically at b selection.
EXPERIMENTAL PROCEDURES
Antibodies, Plasmids, Chemicals
Antibodies and plasmids were gifts, purchased, or generated, as specified
in the Supplemental Experimental Procedures. Cell cycle inhibitors were
purchased.
Retroviral Infections
Virus was made by cotransfecting 293T cells with plasmid and pEco pack-
aging vector. Day 2 supernatants were filtered and used to spin-infect DN3
cells generated from LSK.
OP9 Cocultures
For LSK cocultures, precursors were plated on confluent OP9monolayers and
grown with IL-7 and FLT3L, and fresh media and cytokines were provided
every 4 days. DN3 cocultures were performed without IL-7.
Flow Cytometry and Cell Sorting
Flow cytometry was performed on FACS Aria. Sorted cells were of R98%.
Depletion of DP cells was done with magnetic beads. Cell surface, intracel-
lular, CFSE, and CellTrace Violet staining is described further in detail in the
Supplemental Experimental Procedures. For cell cycle staining, cells were
fixed, permeabilized, treated with RNase A, and stained with DAPI.
Mice
WT and engineered mice were kept at animal facilities of the DFCI, Harvard
Medical School, or of the Department of Molecular Biology, UCSD, according
to institutional, state, and federal guidelines, or purchased from the Jackson
laboratory or Taconic. All animal procedures were done in compliance with
the guidelines of the DFCI Animal Resources Facility, which operates under
regulatory requirements of the U.S. Department of Agriculture and Association
for Assessment and Accreditation of Laboratory Animal Care.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
1016/j.immuni.2012.08.020.
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